scripintelligence.com Report : Visit Site


  • Server:cloudflare...

    The main IP address: 104.27.161.40,Your server Singapore,Singapore ISP:CloudFlare Inc.  TLD:com CountryCode:SG

    The description :a real-time digital news and analysis information service first published more than 40 years ago, scrip now serves the global pharmaceutical industry. headed up by 20 leading editors in key territorie...

    This report updates in 13-Jul-2018

Created Date:2009-07-23
Changed Date:2016-08-02
Expires Date:2018-07-23

Technical data of the scripintelligence.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host scripintelligence.com. Currently, hosted in Singapore and its service provider is CloudFlare Inc. .

Latitude: 1.2896699905396
Longitude: 103.85006713867
Country: Singapore (SG)
City: Singapore
Region: Singapore
ISP: CloudFlare Inc.

the related websites

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.

Expect-CT:max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Content-Encoding:gzip
Transfer-Encoding:chunked
Set-Cookie:__cfduid=df9f787307d7a15b79ca3de126390c25a1531450701; expires=Sat, 13-Jul-19 02:58:21 GMT; path=/; domain=.informa.com; HttpOnly, ASP.NET_SessionId=3zqp3hzp0ukjdptltdkr4it4; path=/; HttpOnly, ASP.NET_SessionId=3zqp3hzp0ukjdptltdkr4it4; path=/; HttpOnly, __RequestVerificationToken=da5BXTEs7lrIjcZ-ftDUgkiKBg0KvFno_AWsrdsBhgIGr5aQjAsgKsndqTH6msuziE1ZOYSGEPG51HvXVMH4yeIsUGMqdEfDr09qyW4cLf81; path=/; HttpOnly, AWSELB=55E70BA3069FF39C047606DF96780969B1E13A603EDF89A7465F941DFDB6480D065437D5999EC8285E4982BE341E71DDA416CC9EAD955864405E288399008545AA88FCCB67;PATH=/;MAX-AGE=54000
Expires:-1
Vary:Accept-Encoding
Server:cloudflare
Connection:keep-alive
Pragma:no-cache
Cache-Control:no-cache, no-store, must-revalidate, no-cache="set-cookie"
Date:Fri, 13 Jul 2018 02:58:21 GMT
X-Frame-Options:SAMEORIGIN
Content-Type:text/html; charset=utf-8
CF-RAY:43987cc21cfb214a-EWR

DNS

soa:art.ns.cloudflare.com. dns.cloudflare.com. 2028112718 10000 2400 604800 3600
ns:art.ns.cloudflare.com.
emma.ns.cloudflare.com.
ipv4:IP:104.27.161.40
ASN:13335
OWNER:CLOUDFLARENET - Cloudflare, Inc., US
Country:US
IP:104.27.160.40
ASN:13335
OWNER:CLOUDFLARENET - Cloudflare, Inc., US
Country:US
ipv6:2400:cb00:2048:1::681b:a128//13335//CLOUDFLARENET - Cloudflare, Inc., US//US
2400:cb00:2048:1::681b:a028//13335//CLOUDFLARENET - Cloudflare, Inc., US//US
txt:"v=spf1 mx include:msgfocus.com include:spf-00030d01.pphosted.com include:outlook.com include:spf.protection.outlook.com include:_netblocks.mimecast.com include:sendgrid.net ?all"
"ms=ms45462395"
mx:MX preference = 10, mail exchanger = us-smtp-inbound-1.mimecast.com.
MX preference = 10, mail exchanger = us-smtp-inbound-2.mimecast.com.

HtmlToText

'); document.write(''); function oas_ad(pos, sector) { if (oas_version = 11 && typeof (oas_rich) != 'undefined') oas_rich(pos); else oas_normal(pos, sector, ''); } function oas_ad_search(pos, sector, keyword) { var sectorname = getcorrespondingsectr(sector); if (oas_version = 11 && typeof (oas_rich) != 'undefined') { oas_rich(pos); } else { oas_normal(pos, sectorname, keyword); } } we use cookies to improve your website experience. to learn about our use of cookies and how you can manage your cookie settings, please see our cookie policy . by continuing to use the website, you consent to our use of cookies. scrip is part of the business intelligence division of informa plc informa plc about us investor relations talent this site is operated by a business or businesses owned by informa plc and all copyright resides with them. informa plc’s registered office is 5 howick place, london sw1p 1wg. registered in england and wales. number 8860726. informa toggle menu menu my view other publications: in vivo | medtech insight | pink sheet | rose sheet start trial register sign in this copy is for your personal, non-commercial use. for high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183 printed by usernamepublicrestriction already registered? sign in to continue reading. sign in thanks, we've sent a link to reset your password forgot your password? enter the email address associated with your account and an email will be sent to you to reset your password. please enter a valid email address. unfortunately we've not been able to process this request. submit need help? email: [email protected] phone: (us toll-free): +1 888-670-8900; (us collect): +1 908-547-2200 phone (uk & europe): +44 (20) 337 73737 phone (apac): +61 2 8705 6907 new to scrip? start a free trial today! free trial register for our free email digests: register toggle menu menu start a trial home my view edit add your favourite topics for quick access commercial companies deals strategy market access market intelligence appointments research & development clinical trials approvals therapy areas pipeline watch policy & regulation hot topics asco coverage brexit pricing debate regional coverage meet the team scrip awards scrip 100 scrip asia 100 ask the analyst pitch pdf library rss feeds subscribe advertise usernamepublicrestriction already registered? sign in to continue reading. sign in thanks, we've sent a link to reset your password forgot your password? enter the email address associated with your account and an email will be sent to you to reset your password. please enter a valid email address. unfortunately we've not been able to process this request. submit need help? email: [email protected] phone: (us toll-free): +1 888-670-8900; (us collect): +1 908-547-2200 phone (uk & europe): +44 (20) 337 73737 phone (apac): +61 2 8705 6907 new to scrip? start a free trial today! free trial register for our free email digests: register don’t miss the 2018 scrip awards ! now is the time to prepare your entry and make sure you take your place among the best! tip: check out our asco annual meeting hot topic page for essential oncology coverage. featured stories bookmark 12 jul 2018 news alarm as novartis exits antibiotics space by kevin grogan the swiss major says that while the science for its antibacterial and antiviral research programs is compelling, "we have decided to prioritize our resources in other areas where we believe we are better positioned to develop innovative medicines." infectious diseases innovation pricing debate bookmark 12 jul 2018 news mylan's fulphila sets up the us market for the next biosimilar showdown by jessica merrill mylan has priced its biosimilar version of pegfilgrastim at a 33% discount to amgen's wac for neulasta, steeper than the 15% discount pfizer initially offered for inflectra. the commercial outcome for fulphila could set the tone for future us biosimilars, which have yet to take off. biosimilars launches pricing strategies bookmark 12 jul 2018 analysis gilenya patent upheld, but who's the biggest winner – novartis or celgene? by mandy jackson a composition of matter patent for the novartis ms drug gilenya expires in 2019, but a recent inter partes review decision upheld a dosing patent that doesn't expire until 2027. however, analysts also touted the victory as a big win for celgene and its competing s1p modulator ozanimod. intellectual property legal issues neurology bookmark 12 jul 2018 news zogenix' zx008 emerges as strong contender in rare epilepsy by emily hayes strong efficacy and a clean safety profile – with no cardiovascular signal – in another phase iii study bode well for filings of zogenix's zx008 in the fourth quarter. latest news gilenya patent upheld, but who's the biggest winner – novartis or celgene? 1 hours ago flurry of marketing collaborations set india deal street abuzz 2 hours ago zogenix' zx008 emerges as strong contender in rare epilepsy 3 hours ago mylan's fulphila sets up the us market for the next biosimilar showdown 6 hours ago genmab moves on from darzalex/tecentriq failure with bispecifics deal 10 hours ago advertisement recent tweets from scrip tweets from https://twitter.com/ibi_tweets/lists/scrip-tweets pharma asset insights innovation in the pharmaceutical industry has never been more exciting, and complicated. disruptive technologies, such as artificial intelligence and digital health tools, and advanced therapeutic modalities including cell and gene therapies and antisense oligonucleotides demand that all health care stakeholders make efforts to move into the next generation of patient care and centricity. pharma asset insights provides a compilation of insights and data-driven analysis. read now and discover more rtsm/irt: a roadmap for developing systems that address current frustrations in a recent study commissioned by oracle health sciences and conducted by informa pharma intelligence, 254 clinical operations, trial management, and related functional professionals responded about the needs of study teams related to existing rtsm/irt solutions. survey results include: the most common frustrations associated with existing rtsm/irt systems the effect of rtsm/irt integration into eclinical platforms opportunities for improving current rtsm/irt systems download the report get our free email newsletter sign up to receive daily alerts from scrip sign up get our free email newsletter newsletter.needsregistrationmessage newsletter.needsregistrationbuttontext get our free email newsletter this email address is already in our system. please click on the button below to sign into your account and update your email preferences. manage preferences commercial explore this topic set alert for commercial cancel remove alert are you sure you'd like to remove this alert? you will no longer receive email updates about this topic. yes, i'm sure bookmark 12 jul 2018 analysis flurry of marketing collaborations set india deal street abuzz by anju ghangurde in-licensing and co-marketing/co-promotion deals are on the up in india, as local and foreign companies tango together to reach more patients and expand their business in the country's competitive market. lupin-boehringer, dr reddy’s-ucb and glenmark-helsinn are among the recent companies doing deals in the area. india commercial deals bookmark 12 jul 2018 analysis otsuka bags novel antibody tech, pipeline in $430m visterra buy by ian haydock otsuka liked the private us antibody tech company visterra so much that it is buying it, in a move developing out of licensing discussions and which the japanese firm says will strengthen its presence in biologics for renal disorders and other high-need areas. m & a biologics renal bookmark 12 jul 2018 news genmab moves on from darzalex/tecentriq failure with bispecifics deal by jo shorthouse genmab is planning for its post-darzale

URL analysis for scripintelligence.com


https://scrip.pharmaintelligence.informa.com/sc123391/downward
eastward
or
inward
blockbuster
film
puts
cancer
drug
prices
in
china
spotlight
https://pharma.id.informa.com/services/apexrest/identity/scrip/services/oauth2/authorize?response_type=code&client_id=3mvg98_psg5cppyasanht6ol6k108drmflc.ojj545_ojelpmkqr2gpbp2jacgk0yzfnfzsyaeybho3yegu0n&redirect_uri=https://scrip.pharmaintelligence.informa.com/user/processuserrequest&state=%2f%3fvid%3dpharma%26processid%3d2e302a2b-1784-4585-9c76-51e0609193d6
https://scrip.pharmaintelligence.informa.com/clinical-and-r-and-d/approvals
https://scrip.pharmaintelligence.informa.com/search#?regions=china
https://scrip.pharmaintelligence.informa.com/search#?subjects=clinical+trials
https://scrip.pharmaintelligence.informa.com/sc123408/zogenix
zx008
emerges
as
strong
contender
in
rare
epilepsy
https://scrip.pharmaintelligence.informa.com/contact-us
https://scrip.pharmaintelligence.informa.com/sc123399/esperion
aims
low
on
price
for
cholesterol
drug
bempedoic
acid
https://scrip.pharmaintelligence.informa.com/authors/john-davis
https://scrip.pharmaintelligence.informa.com/sc123404/genmab
moves
on
from
darzalextecentriq
failure
with
bispecifics
deal
https://scrip.pharmaintelligence.informa.com/articles/2018/07/12/gilenya-patent-upheld-but-whos-the-biggest-winner--novartis-or-celgene
https://scrip.pharmaintelligence.informa.com/authors/sten-stovall
https://scrip.pharmaintelligence.informa.com/commercial/strategy
https://scrip.pharmaintelligence.informa.com/sc123397/indivior
withdraws
2018
guidance
due
to
competitive
pressures
on
suboxone
sublocade
https://scrip.pharmaintelligence.informa.com/authors/brian-yang

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: SCRIPINTELLIGENCE.COM
Registry Domain ID: 1563320120_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2016-08-02T14:00:59Z
Creation Date: 2009-07-23T16:15:21Z
Registrar Registration Expiration Date: 2018-07-23T16:15:21Z
Registrar: Safenames Ltd
Registrar IANA ID: 447
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.1908200022
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Domain Administrator
Registrant Organisation: Informa Group plc
Registrant Street: 30-32 Mortimer Street
Registrant Street:
Registrant City: London
Registrant State/Province: London
Registrant Postal Code: W1W 7RE
Registrant Country: UK
Registrant Phone: +44.2070175000
Registrant Fax:
Registrant Email: [email protected]
Registry Admin ID: Not Available From Registry
Admin Name: Domain Administrator
Admin Organisation: Informa Group plc
Admin Street: 30-32 Mortimer Street
Admin Street:
Admin City: London
Admin State/Province: London
Admin Postal Code: W1W 7RE
Admin Country: UK
Admin Phone: +44.2070175000
Admin Fax:
Admin Email: [email protected]
Registry Tech ID: Not Available From Registry
Tech Name: International Domain Tech
Tech Organisation: International Domain Tech
Tech Street: Safenames House, Sunrise Parkway
Tech Street:
Tech City: Milton Keynes
Tech State/Province: Bucks
Tech Postal Code: MK14 6LS
Tech Country: UK
Tech Phone: +44.1908200022
Tech Fax: +44.1908325192
Tech Email: [email protected]
Name Server: ART.NS.CLOUDFLARE.COM
Name Server: EMMA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2016-08-02T14:00:59Z <<<

"For more information on Whois status codes, please visit https://icann.org/epp"

Safenames - Experts in Global Domain Management and Online Brand Protection

Domain Registration in over 760 different extensions
Enterprise Domain Management since 1999
Mark Protect™ Online Brand Monitoring and Enforcement
Domain Consulting and Strategy
Domain Name Acquisition
Domain Disputes and Recovery

Visit Safenames at www.safenames.net
+1 703 574 5313 in the US/Canada
+44 1908 200022 in Europe

The Data in the Safenames Registrar WHOIS database is provided by Safenames for
information purposes only, and to assist persons in obtaining information about
or related to a domain name registration record. Safenames does not guarantee
its accuracy. Additionally, the data may not reflect updates to billing
contact information.

By submitting a WHOIS query, you agree to use this Data only for lawful purposes
and that under no circumstances will you use this Data to:

(1) allow, enable, or otherwise support the transmission of mass unsolicited,
commercial advertising or solicitations via e-mail, telephone, or facsimile; or
(2) enable high volume, automated, electronic processes that apply to Safenames
(or its computer systems). The compilation, repackaging, dissemination or
other use of this Data is expressly prohibited without the prior written
consent of Safenames. Safenames reserves the right to terminate your access to
the Safenames Registrar WHOIS database in its sole discretion, including
without limitation, for excessive querying of the WHOIS database or for failure
to otherwise abide by this policy. Safenames reserves the right to modify
these terms at any time. By submitting this query, you agree to abide by this
policy.



  REGISTRAR SAFENAMES LTD

  REFERRER http://www.safenames.net

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =scripintelligence.com

  PORT 43

  SERVER whois.safenames.net

  ARGS scripintelligence.com

  PORT 43

  TYPE domain

DOMAIN

  NAME scripintelligence.com

NSERVER

  ART.NS.CLOUDFLARE.COM 173.245.59.102

  EMMA.NS.CLOUDFLARE.COM 173.245.58.112

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

  CHANGED 2016-08-02

  CREATED 2009-07-23

  EXPIRES 2018-07-23

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.uscripintelligence.com
  • www.7scripintelligence.com
  • www.hscripintelligence.com
  • www.kscripintelligence.com
  • www.jscripintelligence.com
  • www.iscripintelligence.com
  • www.8scripintelligence.com
  • www.yscripintelligence.com
  • www.scripintelligenceebc.com
  • www.scripintelligenceebc.com
  • www.scripintelligence3bc.com
  • www.scripintelligencewbc.com
  • www.scripintelligencesbc.com
  • www.scripintelligence#bc.com
  • www.scripintelligencedbc.com
  • www.scripintelligencefbc.com
  • www.scripintelligence&bc.com
  • www.scripintelligencerbc.com
  • www.urlw4ebc.com
  • www.scripintelligence4bc.com
  • www.scripintelligencec.com
  • www.scripintelligencebc.com
  • www.scripintelligencevc.com
  • www.scripintelligencevbc.com
  • www.scripintelligencevc.com
  • www.scripintelligence c.com
  • www.scripintelligence bc.com
  • www.scripintelligence c.com
  • www.scripintelligencegc.com
  • www.scripintelligencegbc.com
  • www.scripintelligencegc.com
  • www.scripintelligencejc.com
  • www.scripintelligencejbc.com
  • www.scripintelligencejc.com
  • www.scripintelligencenc.com
  • www.scripintelligencenbc.com
  • www.scripintelligencenc.com
  • www.scripintelligencehc.com
  • www.scripintelligencehbc.com
  • www.scripintelligencehc.com
  • www.scripintelligence.com
  • www.scripintelligencec.com
  • www.scripintelligencex.com
  • www.scripintelligencexc.com
  • www.scripintelligencex.com
  • www.scripintelligencef.com
  • www.scripintelligencefc.com
  • www.scripintelligencef.com
  • www.scripintelligencev.com
  • www.scripintelligencevc.com
  • www.scripintelligencev.com
  • www.scripintelligenced.com
  • www.scripintelligencedc.com
  • www.scripintelligenced.com
  • www.scripintelligencecb.com
  • www.scripintelligencecom
  • www.scripintelligence..com
  • www.scripintelligence/com
  • www.scripintelligence/.com
  • www.scripintelligence./com
  • www.scripintelligencencom
  • www.scripintelligencen.com
  • www.scripintelligence.ncom
  • www.scripintelligence;com
  • www.scripintelligence;.com
  • www.scripintelligence.;com
  • www.scripintelligencelcom
  • www.scripintelligencel.com
  • www.scripintelligence.lcom
  • www.scripintelligence com
  • www.scripintelligence .com
  • www.scripintelligence. com
  • www.scripintelligence,com
  • www.scripintelligence,.com
  • www.scripintelligence.,com
  • www.scripintelligencemcom
  • www.scripintelligencem.com
  • www.scripintelligence.mcom
  • www.scripintelligence.ccom
  • www.scripintelligence.om
  • www.scripintelligence.ccom
  • www.scripintelligence.xom
  • www.scripintelligence.xcom
  • www.scripintelligence.cxom
  • www.scripintelligence.fom
  • www.scripintelligence.fcom
  • www.scripintelligence.cfom
  • www.scripintelligence.vom
  • www.scripintelligence.vcom
  • www.scripintelligence.cvom
  • www.scripintelligence.dom
  • www.scripintelligence.dcom
  • www.scripintelligence.cdom
  • www.scripintelligencec.om
  • www.scripintelligence.cm
  • www.scripintelligence.coom
  • www.scripintelligence.cpm
  • www.scripintelligence.cpom
  • www.scripintelligence.copm
  • www.scripintelligence.cim
  • www.scripintelligence.ciom
  • www.scripintelligence.coim
  • www.scripintelligence.ckm
  • www.scripintelligence.ckom
  • www.scripintelligence.cokm
  • www.scripintelligence.clm
  • www.scripintelligence.clom
  • www.scripintelligence.colm
  • www.scripintelligence.c0m
  • www.scripintelligence.c0om
  • www.scripintelligence.co0m
  • www.scripintelligence.c:m
  • www.scripintelligence.c:om
  • www.scripintelligence.co:m
  • www.scripintelligence.c9m
  • www.scripintelligence.c9om
  • www.scripintelligence.co9m
  • www.scripintelligence.ocm
  • www.scripintelligence.co
  • scripintelligence.comm
  • www.scripintelligence.con
  • www.scripintelligence.conm
  • scripintelligence.comn
  • www.scripintelligence.col
  • www.scripintelligence.colm
  • scripintelligence.coml
  • www.scripintelligence.co
  • www.scripintelligence.co m
  • scripintelligence.com
  • www.scripintelligence.cok
  • www.scripintelligence.cokm
  • scripintelligence.comk
  • www.scripintelligence.co,
  • www.scripintelligence.co,m
  • scripintelligence.com,
  • www.scripintelligence.coj
  • www.scripintelligence.cojm
  • scripintelligence.comj
  • www.scripintelligence.cmo
Show All Mistakes Hide All Mistakes